Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Micillo

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Pefloxacin in lower respiratory tract infectionsC Grassi, E Catena, G de Iola, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1986
Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative studyG F Abbate, I Alagia, E Giaquinto, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.
Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology GroupG Frasci, N Panza, P Comella, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Pefloxacin in lower respiratory tract infectionsC Grassi, E Catena, G de Iola, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1986
Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative studyG F Abbate, I Alagia, E Giaquinto, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.
Clinical Lung Cancer|January 22, 2004
Interim analysis of a phase III trial comparing cisplatin, gemcitabine, and vinorelbine vs. either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non small-cell lung cancer. A Southern Italy Cooperative Oncology Group StudyP Comella, N Panza, L Manzione, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2000
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology GroupP Comella, G Frasci, N Panza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology GroupG Frasci, N Panza, P Comella, et al.
Pageof 5